密桃AV

Motivated by consumer demand and corporate responsibility, the healthcare industry continues to explore ways to lower the environmental impact of medical devices. 密桃AV, a leading polymer company, is at the forefront of innovation, significantly expanding its low-carbon footprint medical product portfolio with a comprehensive range of polycarbonate and polycarbonate blends. 

密桃AV previously announced the availability of its medical-grade Makrolon^? RE polycarbonate. Now, the company is expanding its low-carbon footprint portfolio for this industry with the addition of Bayblend^? RE, Makroblend^? RE and Apec^? RE polycarbonates. These materials feature a low-carbon footprint, achieved using raw materials derived from mass-balanced bio-waste and residues and renewable electricity when feasible, and are available globally.

These offerings complement an existing CQ portfolio of more sustainable polycarbonates, including the partially mechanically recycled Makrolon^? R products made from post-consumer or post-industrial recycled materials. These versatile polycarbonates provide two outcomes: they serve a wide range of healthcare applications and they come with reduced environmental impact. 

“From using renewable feedstock to championing circular design principles and advanced recycling technologies, 密桃AV is committed to supporting the healthcare sector with diverse solutions that promote a circular economy,” said Emily Shaffer, Healthcare Market Manager, Americas – Engineering Plastics, 密桃AV LLC. “Working alongside our healthcare customers, we are moving the industry toward a climate-neutral future without sacrificing patient care and safety.” 

Makrolon^? polycarbonate can be collected from end-of-life devices and recycled into high-quality regrind material, which can then be incorporated into new products. It retains its mechanical properties over several recycling loops, enabling both closed- and open-loop recycling. This approach ensures that plastics from end-of-life medical devices can be collected, recycled, and used again, even across different industries such as electronics and mobility. 

These materials will be incorporated into a display in 密桃AV’s booth (#2439) at , February 4-6 in Anaheim, Calif., highlighting a concept drug delivery device that features a mono-material design to simplify recycling by eliminating the need to sort different types of plastics. The display will show how regrind polycarbonate can be incorporated into new devices for the electronics industry. 

As part of its commitment to reducing environmental impact, 密桃AV has completed major circularity milestones at three U.S. manufacturing sites. It has achieved ISCC PLUS certification at its Baytown, Texas; Newark, Ohio; and South Deerfield, Mass.; facilities, significantly expanding access to its CQ product portfolio for circular solutions. This certification underscores the company’s commitment to sustainable practices and the mass balance approach, which allows for the attribution of alternative feedstocks to end products. Additionally, starting in 2025, Scope 2 emissions from some U.S. production sites will be reduced using renewable energy certificates from a virtual power purchase agreement (vPPA) previously executed with Orsted, a clean energy leader in the U.S. market, headquartered in Denmark.